Frequency of Toxoplasma gondii in HIV Positive Patients from West of Iran by ELISA and PCR.

  • Ali Rostami School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Hossien Keshavarz School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Saeedeh Shojaee School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Mehdi Mohebali School of Public Health, Tehran University of Medical Sciences, Tehran, Iran ADN Center for Research of Endemic Parasites of Iran (CREPI), Tehran University of Medical Sciences, Tehran, Iran.
  • Ahmad Reza Meamar School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Keywords: Antigenemia, Capture- ELISA, IgG ELISA, PCR, Toxoplasma gondii


Background: Toxoplasma gondii, the obligate intracellular parasite is life threatening in AIDS patients. Diagnosis of toxoplasmosis is based on serological methods especially increasing of IgM and IgG titers, but finding of parasite or its components (antigenemia) may be beneficial method in order to detection of acute toxoplasmosis in immunocompromised patients.Methods: Ninety-four serum samples from HIV positive patients were collected from Sanandaj, Kordistan west of Iran. These patients were lived in Sanandaj of whom 26 were prisoners infected with HIV virus in prison. Toxoplasma gondii antibodies were determined by IgG ELISA. T. gondii antigen was identified by capture-ELISA. PCR was performed on samples with T. gondii antigenemia. CD4+ T cellscounts had been determined by flowcytometry and were obtained from records of each patient.Results: Among the examined HIV seropositive individuals, 19.1% (18/94) and 5.3% (5/94) were positive for Toxoplasma-IgG and antigenemia, respectively. Besides,one of the samples was positively detected by PCR method. Mean age of participants was 37.9 ± 9.5 year. Prevalence of IgG antibody and antgenemia was higher in age group of 40-50 years old. The Mean of CD4+ T cells counts of participants (total of HIV+ patients, IgG positive patients and patients with antigenemia) was 699.2 ± 345.2, 655.1 ± 237.9 and 620.2 ± 215.1 respectively.Conclusion: Capture-ELISA and PCR could confirm the T. gondii acute infection in HIV positive patients. For precise diagnosis of acute toxoplasmosis in HIV positive patient, performance of more studies based on more sensitive types of PCR is suggested. 


Grant IH, Gold WM, Rosenblum M, Niedzwieki D, Armstrong D. Toxoplasma gondii serology in HIV infected patients: the development of central nervous system toxoplasmosis in AIDS. AIDS.1990; 4:519-521.

Botterel F, Lchai P, Feray C, Bouree P, Saliba F, Tur Raspa R, Samuel D, Romand S. Disseminated toxoplasmosis resulting from infection of a allograft, after orthotropic liver transplantation: useful of quantitative PCR. J Clin Microbiol. 2002; 40(5):1648-1650.

Zangerle R, Allerberger E, Pohl P, Fritsch P, Dierich MP. High risk of developing toxoplasmic encephalitis in AIDS patients seropositive to Toxoplasma gondii. Med Microbiol Immunol. 1991; 180:59-66.

Luft BJ, Chua A. Central nervous system toxoplasmosis in HIV: pathogenesis, diagnosis, and therapy. Curr Infect Dis. 2000; 2:358-362.

Hill D, Dubey JP. Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol Infect. 2002; 8:634-640.

Colombo F, Vidal J, Oliveria A, Hernandez A, Filho F, Nogueria R, et al. Diagnosis of cerebral toxoplasmosis in AIDS patients in Brazil: Importance of molecular and immunological methods using peripheral blood samples. J Clin Microbiol. 2005; 43(10):5044-5047.

Vidal J, Valdimir A, Oliveria A, Dauar A, Colombo F, ChiocIcola V. Importance high IgG anti-Toxoplasma gondii titers and PCR detection of T.gondii in peripheral blood samples for the diagnosis of AIDS-related cerebral toxoplasmosis: a case control study. Braz J Infect Dis. 2011; 15(4):356-359.

Shimelis T, Tebeje M, Tadesse E, Tegbaru B, Terefe A. Sero-prevalence of latent Toxoplasma gondii infection among HIV-infected and HIVuninfected people in Addis Ababa, Ethiopia: A comparative cross-sectional study. BMC Research Notes. 2009; 2(213):1-5.

Burg JL, Grove CM, Pouletty P, Boothroyd JC. Directed and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction.J Clin Microbiol. 1989; 27(8):1787-1792.

Luft BJ, Remington JS. Toxoplasmic encephalitis. J Infect Dis.1988; 157 (1):1–6.

Skiest DJ. Focal neurological diseases in patients with acquired immunodeficiency syndrome. Clin Infect Dis. 2002; 34:103-15.

Bastien, P. Molecular diagnosis of toxoplasmosis. Trans R Soc Trop Med Hyg.2002; 96(1):205-215.

Dupon M, Cazenave J, Pellegrin JL, Ragnaud JM, Cheyrou A, Fischer I ,et al. Detection of Toxoplasma gondii by PCR and tissue culture in cerebrospinal fluid and blood of human immunodeficiency virus-seropositive patients. J Clin Microbiol. 1995; 33(9):2421-2426.

Julander I, Matin C, Lappalainen M, Guy E, Isberg B, Evengar B. Polymerase chain reaction for diagnosis of cerebral toxoplasmosis in cerebrospinal fluid in HIV-positive patients. Scand J Infect Dis. 2001; 33:538-541.

Shojaee S, Rezaee S, Keshavarz H. Detection of Toxoplasma gondii from sera and urine of experimentally infected mice by PCR. Pakistan J Biological Sci. 2007; 10(1):193-195.

Ministry of Health of Islamic Republic of Iran, Control of diseases center, Annually AIDS reports, 2013.

Bradford MM. Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochel.1976; 72: 248-254.

Foroghiparvar F, Keshavarz H, Shojaee S. Detection of Toxoplasma gondii antigen in sera and urine of experimentally infected mice by capture- ELISA. Iranian J Parasitol. 2008; 3:1-5.

Knapen F, Panggabean SO. Detection of circulating antigen during acute infections with Toxoplasma gondii by enzyme-linked immunosorbent assay.J Clin Microbiol. 1977; 6(6):545-547.

Araujo FG, Remington JS. Antigenemia in recently acquired acute toxoplasmosis. J Infect Dis. 1980; 141:144-150.

Hassl A, Aspöck H, Flamm H. Circulating antigen of Toxoplasma gondii in patients with AIDS: Significance of detection and structural properties. Zbl Bakt Hyg. 1988; 270:302-309.

Daryani A, Sharif M, Meigouni M. Seroprevalence of IgG and IgM anti-Toxoplasma antibodies in HIV/AIDS patients, northern Iran. Asian Pac J Trop Med. 2011; 4:271-274.

Mardani A, Keshavarz H, Hosseini Ghavanlooei S. Seroprevalence study of antitoxoplasmic antibodies (IgG and IgM) in individuals infected with HIV in Qom regional blood transfusion center. Iranian J Infect Dis Trop Med. 2004; 9(27):19-23.

Shafiei R, Riazi Z, Sarvghad M, Galian Sharifdini M, Mahmoodzadeh A, Hajia M. Prevalence of IgG and IgM Anti-Toxoplasma gondii antibodies in HIV positive patients in northeast of Iran. Iranian J Pathol.2011; 6:68-72.

Mohraz M, Mehrkhani F, Jam S, Seyed Alinaghi A, Sabzvari D, Fattahi F,et al. Seroprevalence of toxoplasmosis in HIV+/AIDS patients in Iran. Acta Medica Iranica.2011; 49(4):213-218.

Davarpanah MD, Mehrabani D, Neirami R, Ghahramanpoori M, Darvish M. Toxoplasmosis in HIV/AIDS patients in Shiraz, southern Iran. Iranian Red Cress Med J. 2007; 9(1):22-27.

Addebbous A, Adarmouch L, Tali A, Laboudi M, Amine M, Aajly L,et al. IgG anti-Toxoplasma antibodies among asymptomatic HIV-infected patients in Marrakesh-Morocco. Acta Trop.2012; 123:49-52.

Laboudi M, Mansouri El B, Sebti F, Amarir F, Coppieters Y, Rhajaoui M. Facteurs de risqué d’une sérologie toxoplasmique positive chez la femme enceinte au Maroc. Parasite.2009; 16:71-72.

Edrisian GH, Rezaeian M, Ghorbani M, Keshavarz H, Mohebali M. Medical protozoology. 1th ed. Tehran University of Medical SciencesPress (in Persian). 2006,p140-150.

Naito T, Inui A, Kudo N, Matsumoto N, Fukuda H, Isonuma H, et al. Seroprevalence of IgG anti-Toxoplasma antibodies in asymptomatic patients infected with human immunodeficiency virus in Japan. Intern Med. 2007; 46:1149-1150.

Nissapatorn V, Lee C, Quek KF, Leong CL, Mahmud R, Abdullah KA. Toxoplasmosis in HIV/AIDS patients: A current situation. Jpn J Infect Dis. 2004; 57:160-165.

Galva Ramirez ML, Valdez Alvarodo V, Vargas Gutierrez G, Jimenez Gonzalez O, Garcia Cosio C, Vielma Sandoval M. Prevalence of IgG and Igm anti-Toxoplasma gondii antibodies in patients with HIV and AIDS. Rev Soc Bras Med Trop. 1997; 30:465-467.

Lones JL, Kruzson D. Toxoplasma gondii infection in US 1999–2000. Emerg Infect Dis. 2003; 9:11.

Boto de Los Bueis A, Vega-Aleman D, Galvez-Acebal J, Merino Muñoz D, Creagh Cerquera R, Pujol de la Llave E. Prevalence of latent Toxoplasma infection in HIV infection patients. Ann Med Intern.1998; 15:298-300.

Kasper L.H, Buzoni-Gatel D. Some Opportunistic Parasitic Infections in AIDS: candidiasis, pneumocystosis, cryptosporidiosis, toxoplasmosis. Parasitol Today. 1998; 14(4):150-157.

Grant IH, Gold WM, Rosenblum M, Niedzwieki D, Armstrong D. Toxoplasma gondii serology in HIV infected patients: the development of central nervous system toxoplasmosis in AIDS. AIDS.1990; 4(6):519-521.

Priya J, Caldero´n MM, Gilman RH, Quispe ML, Cok J, Ticona E, et al. Optimization and evaluation of a PCR assay for detecting toxoplasmic encephalitis in patients with AIDS. J Clin Microbiol. 2002; 40(12):4499-4503.

Vidal JE, Colombo FA, Penalvade Oliveira AC, Focaccia R, Pereira-Chioccola VL. PCR assayusing cerebrospinal fluid for diagnosis of cerebral toxoplasmosis in Brazilian AIDS patients. J Clin Microbiol.2004; 42:4765-4768.

Savva D, Morris JC, Johnson JD, Holliman RE. Polymerase chain reaction for detection of Toxoplasma gondii. J Med Microbiol.1990; 32:25- 31.

Guy EC, Joynson DH. Potential of the polymerase chain reaction in the diagnosis of active Toxoplasma infection by detection of parasite in blood. J Infect Dis. 1995; 172:319-22.

Haghpanah B, Salehi M, Sadri S. Detection of Toxoplasma parasitemia by PCR: does it correlate with IgG and IgM antibody titers? Iran J Immunol. 2006; 3(1):47-53.

How to Cite
Rostami A, Keshavarz H, Shojaee S, Mohebali M, Meamar AR. Frequency of Toxoplasma gondii in HIV Positive Patients from West of Iran by ELISA and PCR. Iran J Parasitol. 9(4):474-481.